GLOBAL TRANSPLANT MARKET SET TO GROW TO $45BN BY 2024, SAYS VISIONGAIN LEAD ANALYST.

Visiongain has launched a new pharma report:
Global Transplant Market Forecast 2019-2029: Tissue Products, Immunosuppressive Drugs, Preservation Solutions, Tissue Transplant, Organ Transplant, Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues, Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant, Hospitals, Transplant Centres, Other End-Users.

The worldwide rise in the demand for tissue or organs for transplant can be attributed to upsurge in the incidence of acute or chronic diseases. For instance, high blood pressure and diabetes are the foremost causes of end-stage kidney conditions, where kidney transplantation or dialysis is the solitary treatment possibilities to save a patient’s life. As stated by the National Kidney Foundation, there were approximately 122,737 patients in the U.S., who are waiting to receive organs for transplantation in 2014. Thus, there is growing demand for high-end tissue products for the treatment of organ damage or failure, and leukaemia treatment.

For free sample pages on this report please click on:
https://www.visiongain.com/report/global-transplant-market-forecast-2019-2029/

The lead analyst of the report commented “Rising number of transplant surgeries, escalating prevalence of chronic diseases, and developing healthcare infrastructure in emerging economies such as China, India, South Africa, Brazil, Mexico, and Indonesia are factors that will drive the demand for transplant products. However, factors such as lack of skilled professionals and high cost of organ transplant surgeries are expected to limit the market growth.”

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 549 9987.

Leading companies featured in the report include AbbVie, Inc., Arthrex, Inc., Medtronic, Novartis AG, Stryker, Teva Pharmaceuticals, Veloxis Pharmaceuticals, Zimmer Biomet.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 549 9987.

For more Pharma reports please visit https://www.visiongain.com/industries/pharma/

Related reports:
• Global Translational Regenerative Medicine Market Prospects 2018-2028
(https://www.visiongain.com/report/global-translational-regenerative-medicine-market-prospects-2018-2028/)
• Global Graft versus Host Disease (GVHD) Market 2017-2027
(https://www.visiongain.com/report/global-graft-versus-host-disease-gvhd-market-2017-2027/)
• Global Ortho and Osteobiologics Market 2018-2028
(https://www.visiongain.com/report/global-ortho-and-osteobiologics-market-2018-2028/)
• Global Stem Cell Technologies and Applications Market 2018-2028
(https://www.visiongain.com/report/global-stem-cell-technologies-and-applications-market-2018-2028/)

Visiongain is one of the fastest-growing and most innovative independent business intelligence providers in Europe.
Based in London, UK, Visiongain publishes independent and insightful market reports across a wide range of industry verticals, including automotive, chemical, cyber, defence, energy, pharmaceutical, materials and many more sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. The company has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original business intelligence to depend upon.
https://www.visiongain.com/

Suite 143, Airport House Purley Way, Croydon CR0 0XZ

This release was published on openPR.